Project 176420

Glucocorticoid regulation of the catabolic effects of parathyroid hormone in bone

176420

Glucocorticoid regulation of the catabolic effects of parathyroid hormone in bone

$100,000
Project Information
Study Type: Unclear
Research Theme: Biomedical
Institution & Funding
Principal Investigator(s): Mitchell, Jane A
Institution: University of Toronto
CIHR Institute: Musculoskeletal Health and Arthritis
Program: Operating Grant - PA: Musculoskeletal Health, Arthritis, Skin and Oral Health
Peer Review Committee: Clinical Investigation - B: Arthritis, Bone, Skin and Cartilage
Competition Year: 2008
Term: 1 yr 0 mth
Abstract Summary

Glucocorticoids are a group of steroid drugs that are used to treat inflammatory conditions such as asthma, arthritis and inflammatory bowel disease. One of the major side-effects of these drugs is osteoporosis in which the bones become weak and prone to fracture. Research has shown that glucocorticoids alter the response of bone cells to endogenous hormones resulting in less bone deposition and eventual osteoporosis. We have examined the effects of glucocorticoids on osteoblasts, the cells that make bone, and found that they alter the responses to hormones such and parathyroid hormone (PTH). In our current work we will continue to identify the key changes to signaling in osteoblasts and test the effects of these changes in mouse models. By understanding these changes we may be able to find ways to avoid osteoporosis when patients have to take steroid antiinflammatory drugs.

No special research characteristics identified

This project does not include any of the advanced research characteristics tracked in our database.

Keywords
Beta-Adrenergic Agonists Bone Glucocorticoids Osteoporosis Parathyroid Hormone Transcription Factors